Main Menu

The Adult Drug Development Unit at the ICR and the RM

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading team of >100 staff focused on early anti-cancer drug development.

Team leader

Professor Johann de Bono

Professor Johann de Bono

Regius Professor of Cancer Research

Professor Johann de Bono is the Head of the Division of Clinical Studies and an international expert in the development of novel anticancer therapies against adult cancers. His team of runs one of the world’s largest phase I clinical trials units for cancer, with >100 staff including dedicated radiology and pathology staff; he also runs a separate team focused on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA.

ORCID 0000-0002-2034-595X